Log In
BCIQ
Print this Print this
 

177-Lu-Dotatate, 177Lu-DOTA0-Tyr3-Octreotate, Lutathera

  Manage Alerts
Collapse Summary General Information
Company Advanced Accelerator Applications S.A.
DescriptionRadiolabeled somatostatin analog that targets somatostatin receptors
Molecular Target Somatostatin receptor
Mechanism of ActionRadiolabelled antibody
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/30/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today